This Week in Health CareSM, April 18, 2018
Every Wednesday, Stateside Associates selects some health care-related state and local events to highlight in This Week in Health Care.
To provide feedback, or for more information about these issues or Stateside Associates’ Health Care Practice, please contact Robert Holden at (703) 525-7466 or firstname.lastname@example.org.
The National Association of County and City Health Officials will hold its Preparedness Summit April 17-20 in Atlanta, Georgia. Robert Holden at email@example.com
The Assembly Committee on Appropriations will hold a public hearing April 18 regarding A.B. 2174, which requires the Department of Public Health to establish a public awareness campaign on the effects and warning signs of heroin use and opioid medication and the available pathways for individuals seeking help. Thomas Waldrop at firstname.lastname@example.org
The Senate Judiciary Committee will hold a public hearing April 23 regarding H.B. 1307, which states that it is unlawful for a seller, retailer or vendor to knowingly or willfully dispense, sell or distribute a finished drug product containing any quantity of dextromethorphan to a person less than 18 years of age. Andrew O’Connor at email@example.com
The Agency for Health Care Administration will accept comments until April 24 regarding proposed rules concerning behavioral health services, including a rule concerning behavioral health medication management services. Becky Lukaesko at firstname.lastname@example.org
The Department of Health and Human Services will accept comments until April 20 regarding an interim rule concerning pharmaceutical services available through the state Medicaid program. Brian LeFort at email@example.com
The Board of Pharmacy will accept comments until April 20 regarding proposed amendments to the controlled substance rules and aligning the state rules with DEA registrations. Melissa Martin at firstname.lastname@example.org
The House Corporations Committee will hold a public hearing April 24 regarding H.B. 7684, which regulates pharmacy benefits manager audits of pharmacies and establishes reporting requirements for health insurers. Thomas Waldrop at email@example.com